Skip to main content

Table 3 Compliance with trial protocol

From: Effect of intermediate care on mortality following emergency abdominal surgery. The InCare trial: study protocol, rationale and feasibility of a randomised multicentre trial

Measures IC Group (day 2)a WC Group (day 14)a
Actual monitoring level   
Level of consciousness (number of registrations) x x
Respiratory rate (number of registrations) x x
Continuous pulse oximetry (yes/no) x x
Blood pressure (number of registrations) x x
Continuous ECG monitoring (yes/no) x x
24-h diuresis (number of registrations) x x
Hourly diuresis registration for >24 h (yes/no) x x
Temperature (number of registrations) x x
Pain Visual Assessment Score (no. of registrations) x x
Central venous pressure (number of registrations) x x
Central venous oxygen saturation (number of samples) x x
Standard blood samples (number of samples) x x
Treatment level   
Infusion of sympathomimetic drugs (yes/no) x x
Parallel infusion of sympathomimetic drugs (yes/no) x x
>2 L supplemental oxygen during nights (yes/no) x x
Assistance to PEP therapy (number of treatments) x x
Non-invasive ventilation (yes/no) x x
Invasive ventilation (yes/no) x x
Emergency dialysis (yes/no) x x
24-h fluid balance calculation (number of registrations) x x
Protocol-based discharge by anaesthetist (yes/no)b   x
Protocol-based round by intensivist (number) x  
Protocol-based round by surgeon (number) x  
Patient location (hours)c x x
  1. Data stem from medical charts, nurse charts and observation charts used in the 48-h intervention period.
  2. aTiming of registration of compliance to protocol in the case report form.
  3. bRegistered by the anaesthetist writing the discharge note and checked at day 14.
  4. cPost-anaesthesia care unit; intermediate care bed; intensive care bed; surgical ward; medical ward; and/or coronary care unit.